Open AccessOsteonecrosis of jaw associated with bisphosphonate use
Author(s) -
Ashu Rastogi,
Vidya Rattan,
Sanjay Kumar Bhadada
Publication year - 2012
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/2230-8210.95711
Subject(s) - medicine , osteonecrosis of the jaw , teriparatide , maxilla , bisphosphonate associated osteonecrosis of the jaw , mandible (arthropod mouthpart) , dentistry , osteoporosis , bisphosphonate , surgery , bone mineral , botany , biology , genus
Bisphosphonates are associated with osteonecrosis of the jaw (ONJ) that is defined as an area of exposed, nonvital bone in the maxilla or mandible persisting over 6-8 weeks. We describe a case of 55-year-old female who developed ONJ after tooth extraction and had been receiving oral ibandronate for osteoporosis. Diagnosis of ONJ was confirmed on CT scan. The patient was managed conservatively as she denied teriparatide therapy because of cost constraints.